[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - September 2004

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 76-739 FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE TABLETS 10 MG/12.5 MG and 20 MG/12.5 MG   RANBAXY PHARMACEUTICALS, INC. 9/1/2004 
2 76-874 LEVOFLOXACIN TABLETS 250 MG, 500 MG, AND 750 MG   RANBAXY LABORATORIES LIMITED 9/9/2004 
3 76-537 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG   MUTUAL PHARMACEUTICAL COMPANY, INC. 9/20/2004 
4 76-581 CETIRIZINE HYDROCHLORIDE TABLETS 5 MG AND 10 MG   TEVA PHARMACEUTICALS USA 9/21/2004 
5 76-475 TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN TABLETS 37.5 MG/325 MG   KALI LABORATORIES 9/22/2004 
6 76-992 CIPROFLOXACIN INJECTION, USP 10 MG/ML; PACKAGED IN 200 MG/20 ML AND 400 MG/40 ML SINGLE-DOSE VIALS   BEDFORD LABORATORIES 9/23/2004 
7 76-872 HALOBETASOL PROPIONATE OINTMENT 0.05%   AGIS INDUSTRIES (1983) LTD. 9/24/2004 
8 76-277 RIBAVIRIN CAPSULES 200 MG   TEVA PHARMACEUTICALS USA 9/24/2004 
9 76-818 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 500 MG   COBALT PHARMACEUTICALS, INC. 9/27/2004 
10 76-869 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 750 MG   ANDRX PHARMACEUTICALS LLC 9/29/2004 

Back to Top     Back to Approvals

Date created: October 5, 2004

horizonal rule